Details for New Drug Application (NDA): 202176
✉ Email this page to a colleague
The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for 202176
| Tradename: | LANSOPRAZOLE |
| Applicant: | Wockhardt Bio Ag |
| Ingredient: | lansoprazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202176
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 15MG | ||||
| Approval Date: | Sep 14, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 30MG | ||||
| Approval Date: | Sep 14, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
